Cellceutix Corp. closed a direct offering of about $2.2 million of its class A common stock.

The company sold 2,471,912 shares to certain investors at 89 cents apiece without an underwriter or placement agent.

Cellceutix plans to use the net proceeds for general corporate purposes.